A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Bill S 4152 is currently in the status of Bill Introduced since May 5, 2022. Bill S 4152 was introduced during Congress 117 and was introduced to the Senate on May 5, 2022.  Bill S 4152's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 5, 2022